Urinary kallikrein excretion after DDAVP
✍
D. G. Waller; S. K. Campbell; J. D. M. Albano
📂
Article
📅
1988
🏛
John Wiley and Sons
🌐
English
⚖ 270 KB
Several factors are believed to contribute to impaired responsiveness to arginine vasopressin (AVP) during lithium treatment. The renal kallikrein-kinin system is reported to antagonize the renal effects of AVP in vitro, but there are no reports of its activity during lithium treatment. Urinary acti